insights_auto
Outlook: 66.7% bullish·3.0% bearish
Go to analysischevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
1,46 $
arrow_downward
-1,02%(-0,015) 1D
1,45 $
arrow_downward
-0,66% (-0,0097)bedtimeAfter hours
Closed: 12 նոյ, 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
1,44 $
High
1,53 $
Low
1,33 $
Mkt. cap
272,54 մլն
Avg. vol.
19,06 մլն
Volume
7,39 մլն
52-wk high
2,72 $
52-wk low
0,56 $
EPS
-1,17 $
Beta
1,71
Shares outstanding
187,31 մլն
No. of employees
112
Open
1,44 $
High
1,53 $
Low
1,33 $
Mkt. cap
272,54 մլն
Avg. vol.
19,06 մլն
Volume
7,39 մլն
52-wk high
2,72 $
52-wk low
0,56 $
EPS
-1,17 $
Beta
1,71
Shares outstanding
187,31 մլն
No. of employees
112
News stories
From web sources and news partners
GuruFocus
·
9 ժամ առաջ
Inovio Pharmaceuticals Inc (INO) (Q3 2026) Earnings Call Highlig
Yahoo Finance
·
1 օր առաջ
Inovio Pharmaceuticals, Inc. Q3 2026 Earnings Call Summary
TradingView
·
1 օր առաջ
Inovio Pharmaceuticals Q3 Earnings Call Highlights
Yahoo Finance
·
1 օր առաջ
Inovio: Q3 Earnings Snapshot
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc